Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0000950170-24-013922 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-02-12 | 2024-02-08+ | DLB | Couling John D | SVP, Entertainment | M - OptEx | $47.87 | +83.6K | 121.0K | +223% | +$4.00M |
| DMT | 2024-02-12 | 2024-02-08+ | DLB | Couling John D | SVP, Entertainment | S - Sale+OE | $80.33 | -83.6K | 108.5K | -44% | -$6.71M |
| DMT | 2024-02-12 | 2024-02-08+ | DLB | Couling John D | SVP, Entertainment | M - OptEx | $0.00 | -83.6K | 12.4K | -87% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-09 | M | A | 21,120 | $62.32 | 142,079 | D | — | — | (F1) Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| 2 | Common | Class A Common Stock | 2024-02-09 | S | D | 33,560 | $80.81 | 108,519 | D | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $80.45 to $81.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F1) Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| 3 | Common | Class A Common Stock | 2024-02-08 | S | D | 50,000 | $80.00 | 108,519 | D | — | — | (F1) Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| 4 | Common | Class A Common Stock | 2024-02-08 | M | A | 50,000 | $42.98 | 158,519 | D | — | — | (F1) Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| 5 | Common | Class A Common Stock | 2024-02-09 | M | A | 12,440 | $42.98 | 120,959 | D | — | — | (F1) Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2024-02-09 | M | D | 21,120 | $0.00 | 0 | D | $62.32 · — to 2024-12-15 | 21,120 Class A Common Stock | (F4) This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 21,120. shares. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2024-02-09 | M | D | 12,440 | $0.00 | 0 | D | $42.98 · — to 2024-12-15 | 12,440 Class A Common Stock | (F3) This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2024-02-08 | M | D | 50,000 | $0.00 | 12,440 | D | $42.98 · — to 2024-12-15 | 50,000 Class A Common Stock | (F3) This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. |